352 related articles for article (PubMed ID: 19692689)
1. Diacetylmorphine versus methadone for the treatment of opioid addiction.
Oviedo-Joekes E; Brissette S; Marsh DC; Lauzon P; Guh D; Anis A; Schechter MT
N Engl J Med; 2009 Aug; 361(8):777-86. PubMed ID: 19692689
[TBL] [Abstract][Full Text] [Related]
2. Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence: A Randomized Clinical Trial.
Oviedo-Joekes E; Guh D; Brissette S; Marchand K; MacDonald S; Lock K; Harrison S; Janmohamed A; Anis AH; Krausz M; Marsh DC; Schechter MT
JAMA Psychiatry; 2016 May; 73(5):447-55. PubMed ID: 27049826
[TBL] [Abstract][Full Text] [Related]
3. Double-blind injectable hydromorphone versus diacetylmorphine for the treatment of opioid dependence: a pilot study.
Oviedo-Joekes E; Guh D; Brissette S; Marsh DC; Nosyk B; Krausz M; Anis A; Schechter MT
J Subst Abuse Treat; 2010 Jun; 38(4):408-11. PubMed ID: 20359843
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of hydromorphone for severe opioid use disorder: findings from the SALOME randomized clinical trial.
Bansback N; Guh D; Oviedo-Joekes E; Brissette S; Harrison S; Janmohamed A; Krausz M; MacDonald S; Marsh DC; Schechter MT; Anis AH
Addiction; 2018 Jul; 113(7):1264-1273. PubMed ID: 29589873
[TBL] [Abstract][Full Text] [Related]
5. Safety profile of injectable hydromorphone and diacetylmorphine for long-term severe opioid use disorder.
Oviedo-Joekes E; Brissette S; MacDonald S; Guh D; Marchand K; Jutha S; Harrison S; Janmohamed A; Zhang DZ; Anis AH; Krausz M; Marsh DC; Schechter MT
Drug Alcohol Depend; 2017 Jul; 176():55-62. PubMed ID: 28521199
[TBL] [Abstract][Full Text] [Related]
6. Client satisfaction among participants in a randomized trial comparing oral methadone and injectable diacetylmorphine for long-term opioid-dependency.
Marchand KI; Oviedo-Joekes E; Guh D; Brissette S; Marsh DC; Schechter MT
BMC Health Serv Res; 2011 Jul; 11():174. PubMed ID: 21791093
[TBL] [Abstract][Full Text] [Related]
7. Predictors of non-use of illicit heroin in opioid injection maintenance treatment of long-term heroin dependence.
Oviedo-Joekes E; Sordo L; Guh D; Marsh DC; Lock K; Brissette S; Anis AH; Schechter MT
Addict Behav; 2015 Feb; 41():81-6. PubMed ID: 25452049
[TBL] [Abstract][Full Text] [Related]
8. The suitability of oral diacetylmorphine in treatment-refractory patients with heroin dependence: A scoping review.
F Martins ML; Wilthagen EA; Oviedo-Joekes E; Beijnen JH; de Grave N; Uchtenhagen A; Beck T; Van den Brink W; Schinkel AH
Drug Alcohol Depend; 2021 Oct; 227():108984. PubMed ID: 34482044
[TBL] [Abstract][Full Text] [Related]
9. Drug use, health and social outcomes of hard-to-treat heroin addicts receiving supervised injectable opiate treatment: secondary outcomes from the Randomized Injectable Opioid Treatment Trial (RIOTT).
Metrebian N; Groshkova T; Hellier J; Charles V; Martin A; Forzisi L; Lintzeris N; Zador D; Williams H; Carnwath T; Mayet S; Strang J
Addiction; 2015 Mar; 110(3):479-90. PubMed ID: 25251885
[TBL] [Abstract][Full Text] [Related]
10. Supervised injectable heroin or injectable methadone versus optimised oral methadone as treatment for chronic heroin addicts in England after persistent failure in orthodox treatment (RIOTT): a randomised trial.
Strang J; Metrebian N; Lintzeris N; Potts L; Carnwath T; Mayet S; Williams H; Zador D; Evers R; Groshkova T; Charles V; Martin A; Forzisi L
Lancet; 2010 May; 375(9729):1885-95. PubMed ID: 20511018
[TBL] [Abstract][Full Text] [Related]
11. Differential long-term outcomes for voluntary and involuntary transition from injection to oral opioid maintenance treatment.
Oviedo-Joekes E; Guh D; Marchand K; Marsh DC; Lock K; Brissette S; Anis AH; Schechter MT
Subst Abuse Treat Prev Policy; 2014 Jun; 9():23. PubMed ID: 24908387
[TBL] [Abstract][Full Text] [Related]
12. Men's and women's response to treatment and perceptions of outcomes in a randomized controlled trial of injectable opioid assisted treatment for severe opioid use disorder.
Palis H; Marchand K; Guh D; Brissette S; Lock K; MacDonald S; Harrison S; Anis AH; Krausz M; Marsh DC; Schechter MT; Oviedo-Joekes E
Subst Abuse Treat Prev Policy; 2017 May; 12(1):25. PubMed ID: 28526048
[TBL] [Abstract][Full Text] [Related]
13. History of reported sexual or physical abuse among long-term heroin users and their response to substitution treatment.
Oviedo-Joekes E; Marchand K; Guh D; Marsh DC; Brissette S; Krausz M; Anis A; Schechter MT
Addict Behav; 2011; 36(1-2):55-60. PubMed ID: 20855171
[TBL] [Abstract][Full Text] [Related]
14. Feasibility of double-blind clinical trials with oral diacetylmorphine: a randomized controlled phase II study in an inpatient setting.
Colom Farran J; Casas M; Pérez de Los Cobos J; Del Río M; Roncero C; Castells X; Valero S; Eiroa-Orosa FJ; Batlle F; Trujols J
Eur Addict Res; 2012; 18(6):279-87. PubMed ID: 22854605
[TBL] [Abstract][Full Text] [Related]
15. Scientific and political challenges in North America's first randomized controlled trial of heroin-assisted treatment for severe heroin addiction: rationale and design of the NAOMI study.
Oviedo-Joekes E; Nosyk B; Marsh DC; Guh D; Brissette S; Gartry C; Krausz M; Anis A; Schechter MT
Clin Trials; 2009 Jun; 6(3):261-71. PubMed ID: 19528135
[TBL] [Abstract][Full Text] [Related]
16. The SALOME study: recruitment experiences in a clinical trial offering injectable diacetylmorphine and hydromorphone for opioid dependency.
Oviedo-Joekes E; Marchand K; Lock K; MacDonald S; Guh D; Schechter MT
Subst Abuse Treat Prev Policy; 2015 Jan; 10():3. PubMed ID: 25619263
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence.
Oviedo-Joekes E; Palis H; Guh D; Marchand K; Brissette S; Lock K; MacDonald S; Harrison S; Anis AH; Krausz M; Marsh DC; Schechter MT
Drug Alcohol Rev; 2018 Jan; 37(1):137-146. PubMed ID: 28593748
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and response to treatment among Aboriginal people receiving heroin-assisted treatment.
Oviedo-Joekes E; Guh D; Marsh DC; Brissette S; Nosyk B; Krausz M; Anis A; Christian WM; Spittal P; Schechter MT
Can J Public Health; 2010; 101(3):210-2. PubMed ID: 20737811
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of cocaine contingency management in heroin-assisted treatment: Results of a randomized controlled trial.
Blanken P; Hendriks VM; Huijsman IA; van Ree JM; van den Brink W
Drug Alcohol Depend; 2016 Jul; 164():55-63. PubMed ID: 27177805
[TBL] [Abstract][Full Text] [Related]
20. Adverse Events During Treatment Induction With Injectable Diacetylmorphine and Hydromorphone for Opioid Use Disorder.
Oviedo-Joekes E; Palis H; Guh D; Marsh DC; MacDonald S; Harrison S; Brissette S; Anis AH; Schechter MT
J Addict Med; 2019; 13(5):354-361. PubMed ID: 30747750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
